TAZOP-4.5 Injection

Description

AZOP-4.5 Injection contains Piperacillin (4 g) and Tazobactam (0.5 g), a powerful combination that provides broad-spectrum antibacterial activity against both gram-positive and gram-negative bacteria. Piperacillin, a penicillin-class antibiotic, works by inhibiting bacterial cell wall synthesis, while Tazobactam, a beta-lactamase inhibitor, prevents resistance by inhibiting bacterial enzymes that degrade antibiotics. This combination is commonly used to treat severe infections, including respiratory tract infections, urinary tract infections, intra-abdominal infections, and sepsis. TAZOP-4.5 Injection is administered intravenously under medical supervision in a hospital or clinical setting for optimal effectiveness.

Specifications

• Formulation: Sterile powder for reconstitution
• Active Ingredients: Piperacillin 4 g and Tazobactam 0.5 g
• Strength: 4.5 g per vial
• Packaging: Single-use vial, with sterile powder for reconstitution
• Storage Instructions: Store below 25°C. Keep in a dry place and protect from light.

Features

• Broad-spectrum Activity: Effective against a variety of gram-positive and gram-negative bacteria, including resistant strains.
• Dual Mechanism: Combines Piperacillin for cell wall inhibition with Tazobactam to counteract beta-lactamase resistance.
• High Potency: Strong formulation for treating severe infections that do not respond to standard antibiotics.
• Intravenous Administration: Direct IV administration ensures rapid action, especially in critical care situations.
• Widely Applicable: Used in diverse infections, including respiratory, urinary, and abdominal

Benefits

• Effective Against Resistant Infections: Tazobactam helps prevent bacterial resistance, enhancing the efficacy of Piperacillin.
• Rapid Symptom Relief: IV administration allows for quick absorption and rapid onset of action, ideal for severe infections.
• Comprehensive Infection Control: Treats a wide range of infections, making it suitable for critically ill patients.
• Well-studied Combination: Proven effective and safe in clinical settings, trusted by healthcare providers.
• Flexible Dosing: Available in a potent 4.5 g dose that can be adjusted according to the severity of infection.

Usage Instructions

• Purpose: For the treatment of moderate to severe bacterial infections as directed by a healthcare professional.
• Dosage:
  • Adults: Typically administered as 4.5 g every 6-8 hours by intravenous infusion. Dosage may vary based on infection severity and patient health.
  • Children: Dosage based on weight; administered under strict medical supervision.

• How to Use:
  • Reconstitute the powder with the appropriate amount of sterile water or saline solution before administration.
  • Administer by slow IV infusion over 30 minutes as directed by a healthcare provider.
  • Complete the full prescribed course to prevent bacterial resistance.

Warnings:

• Do not use if allergic to penicillin, cephalosporin, or beta-lactam antibiotics.
• Caution in patients with kidney disease; dosage adjustment may be required.
• Potential for drug interactions; inform the healthcare provider of all medications.
• Not recommended for use during pregnancy or breastfeeding unless deemed necessary by a physician.

Side Effects:

Common side effects may include nausea, vomiting, diarrhea, and mild injection site reactions. Rare side effects may include allergic reactions, kidney issues, or abnormal blood counts. Seek medical assistance for severe side effects.